Grant: Master's Award: Canada Graduate Research Scholarships - Master's program
McMaster University
$27,000.00
Exploring the Role of Microbial Histamine and Cadaverine in Inflammatory Bowel Disease (IBD)
EF 2025-26
Résumé
Inflammatory bowel disease (IBD) is characterized as a group of chronic inflammatory gastrointestinal (GI) disorders. Challenges surrounding IBD treatment—including non-responders to current IBD medications and post-inflammatory abdominal pain—presents a need for novel therapeutics. The gut microbiota is an attractive candidate when identifying novel targets for IBD. Recent findings on histamine receptor activation by microbial-derived histamine and cadaverine in abdominal pain and colonic inflammation respectively show potential for investigation. However, whether microbiota-mediated activation of histamine receptors in the gut is implicated in chronic abdominal pain in IBD is unclear. My hypothesis is that microbial-derived histamine and cadaverine acts on histamine receptors to induce visceral pain in IBD. Firstly, I will quantify histamine receptors H1, H2, H3, and H4 in the small intestine and colon using previously colonized mice with microbiota from either patients with IBD or healthy volunteers. Next, I will assess if histamine receptors’ activation associate with pain by colonizing additional mice with microbiota from IBD patients with either high histamine or cadaverine. I will determine the capacity of IBD-associated microbiota to produce histamine and cadaverine in vitro, and by using in silico techniques (shotgun metagenomic sequencing on a cohort of IBD patients), I will determine the expression of genes linked to histamine and cadaverine production and degradation. In conclusion, my project will add to the limited research available on the link between histamine receptor activation and abdominal pain in IBD. This may contribute to the design of new approaches for personalized medicine towards treating individuals living with IBD.
Programme
Master's Award: Canada Graduate Research Scholarships - Master's program
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
572680
Name
Jiang Anran
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Exploring the Role of Microbial Histamine and Cadaverine in Inflammatory Bowel Disease (IBD)
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Gastroenterology; Gut Microbiota; Histamine; Histamine Receptors; Inflammatory Bowel Disease; Metabolism; Microbiology; Nutrition; Pathophysiology; Visceral Pain/Visceral Hypersensitivity
Abstract
Inflammatory bowel disease (IBD) is characterized as a group of chronic inflammatory gastrointestinal (GI) disorders. Challenges surrounding IBD treatment—including non-responders to current IBD medications and post-inflammatory abdominal pain—presents a need for novel therapeutics. The gut microbiota is an attractive candidate when identifying novel targets for IBD. Recent findings on histamine receptor activation by microbial-derived histamine and cadaverine in abdominal pain and colonic inflammation respectively show potential for investigation. However, whether microbiota-mediated activation of histamine receptors in the gut is implicated in chronic abdominal pain in IBD is unclear. My hypothesis is that microbial-derived histamine and cadaverine acts on histamine receptors to induce visceral pain in IBD. Firstly, I will quantify histamine receptors H1, H2, H3, and H4 in the small intestine and colon using previously colonized mice with microbiota from either patients with IBD or healthy volunteers. Next, I will assess if histamine receptors’ activation associate with pain by colonizing additional mice with microbiota from IBD patients with either high histamine or cadaverine. I will determine the capacity of IBD-associated microbiota to produce histamine and cadaverine in vitro, and by using in silico techniques (shotgun metagenomic sequencing on a cohort of IBD patients), I will determine the expression of genes linked to histamine and cadaverine production and degradation. In conclusion, my project will add to the limited research available on the link between histamine receptor activation and abdominal pain in IBD. This may contribute to the design of new approaches for personalized medicine towards treating individuals living with IBD.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Jiang, Anran
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~